Form 4: LENSAR Director Todd Hammer Awarded 17,421 RSUs

LENSAR, Inc. director and major shareholder Todd B. Hammer received an annual grant of 17,421 restricted stock units as part of the company's director compensation program.

Summary

• Todd B. Hammer, a Director and 10% owner of LENSAR, Inc., was granted 17,421 Restricted Stock Units (RSUs) on June 3, 2026.
• Each RSU represents a contingent right to receive one share of common stock, with full vesting scheduled for June 3, 2027.
• Following the transaction, Hammer directly owns 56,083 shares of common stock.
• Hammer also maintains a significant indirect interest in 1,100,592 shares held by North Run Capital, LP.
• The grant was issued as standard annual compensation for non-employee directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive routine administrative event that confirms continued insider alignment and commitment to the company.

Positives

• Director and 10% owner continues to increase direct equity stake, further aligning interests with common shareholders.
• Significant indirect ownership of over 1.1 million shares demonstrates long-term institutional commitment from the reporting person.
• The RSU structure ensures the director remains incentivized through at least the mid-2027 vesting date.

Negatives

• The issuance of RSUs represents a small degree of future equity dilution for existing shareholders.

Risks

• Vesting is contingent upon continued service through June 3, 2027; early termination of service would result in forfeiture.
• The ultimate value of the compensation is subject to market volatility and the future share price of LNSR.

Future Outlook

The reporting person is expected to remain in a governance role through at least June 2027 to satisfy vesting requirements, maintaining stability within the board of directors.

Management Comments

• The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard industry practice in the medical technology sector to ensure board members are motivated to drive long-term shareholder value rather than short-term gains.

Comparison to Industry Standards

• The grant size is consistent with annual equity awards for directors in small-cap healthcare and medical device companies.
• A one-year cliff vesting schedule is the standard benchmark for annual board service awards in the U.S. market.

Corporate Governance

Related Party Transactions

• Todd Hammer is a member of North Run Advisors, LLC, which serves as the general partner for North Run Capital, LP, a 10% owner of LENSAR, Inc.

Stakeholder Impact

• Shareholders face minor dilution upon the future settlement of these RSUs.
• The board maintains the expertise of a significant stakeholder and experienced director.

Next Steps

• Vesting of the 17,421 RSUs on June 3, 2027, subject to continued service.

Key Dates

Recommendation

This filing reflects routine director compensation and does not signal a change in company fundamentals or strategic direction that would warrant a change in investment thesis.

Keywords

LENSAR, LNSR, Insider Trading, Form 4, Restricted Stock Units, Director Compensation, North Run Capital, Todd Hammer, Medical Devices